1. Home
  2. PT vs GLYC Comparison

PT vs GLYC Comparison

Compare PT & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • GLYC
  • Stock Information
  • Founded
  • PT 2012
  • GLYC 2003
  • Country
  • PT China
  • GLYC United States
  • Employees
  • PT N/A
  • GLYC N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • GLYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • GLYC Health Care
  • Exchange
  • PT Nasdaq
  • GLYC Nasdaq
  • Market Cap
  • PT 15.8M
  • GLYC 15.9M
  • IPO Year
  • PT 2018
  • GLYC 2014
  • Fundamental
  • Price
  • PT $1.01
  • GLYC $0.22
  • Analyst Decision
  • PT
  • GLYC Hold
  • Analyst Count
  • PT 0
  • GLYC 3
  • Target Price
  • PT N/A
  • GLYC N/A
  • AVG Volume (30 Days)
  • PT 12.3K
  • GLYC 286.7K
  • Earning Date
  • PT 04-29-2025
  • GLYC 05-08-2025
  • Dividend Yield
  • PT N/A
  • GLYC N/A
  • EPS Growth
  • PT N/A
  • GLYC N/A
  • EPS
  • PT N/A
  • GLYC N/A
  • Revenue
  • PT $4,814,566.00
  • GLYC N/A
  • Revenue This Year
  • PT N/A
  • GLYC N/A
  • Revenue Next Year
  • PT N/A
  • GLYC N/A
  • P/E Ratio
  • PT N/A
  • GLYC N/A
  • Revenue Growth
  • PT N/A
  • GLYC N/A
  • 52 Week Low
  • PT $0.71
  • GLYC $0.14
  • 52 Week High
  • PT $1.19
  • GLYC $2.36
  • Technical
  • Relative Strength Index (RSI)
  • PT 51.85
  • GLYC 47.98
  • Support Level
  • PT $0.92
  • GLYC $0.17
  • Resistance Level
  • PT $1.03
  • GLYC $0.22
  • Average True Range (ATR)
  • PT 0.04
  • GLYC 0.02
  • MACD
  • PT 0.00
  • GLYC 0.00
  • Stochastic Oscillator
  • PT 75.00
  • GLYC 83.33

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Share on Social Networks: